[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Doric Nimrod Air One Limited LSE:DNA London Ordinary Share GG00B4MF3899 ORD PRF SHS NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 32.00 30.00 34.00 32.00 32.00 32.00 0.00 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 -13.8 -32.4 - 14

Doric Nimrod Air One Share Discussion Threads

Showing 1 to 10 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
12/1/2005
07:18
ZURICH (AFX) - Roche Holding AG confirmed that the US Food and Drug Administration (FDA) has approved its microarray-based test, the AmpliChip CYP450 Test, for diagnostic use in the US. The test analyses a patient's DNA and helps doctors in choosing medication for a wide variety of common conditions such as cardiac diseases, pain and cancer, the Swiss drugs and diagnostics group said in a statement. The test was launched in Europe in autumn 2004. scs/jfr
grupo
05/1/2005
21:04
Maclyn McCarty, put DNA in the map Email this story Printer friendly format Enter a Category View List BY DELTHIA RICKS STAFF WRITER January 5, 2005 Dr. Maclyn McCarty, the last surviving member of the Manhattan team who provided the world's first convincing evidence that genes are made of DNA, died Sunday in Manhattan of congestive heart failure. He was 93. As a professor at Rockefeller University and as a former physician-in-chief at Rockefeller University Hospital, McCarty brought an unmatched level of creativity and inquisitiveness to some of the more profound questions in mid-20th century science, fellow researchers say. The DNA discovery was so important that scientists remain surprised that McCarty and his colleagues, Dr. Oswald T. Avery and Colin MacLeod, did not win the Nobel Prize for their groundbreaking work in 1944. Avery, who led the group, had been attempting to unravel the mysteries of the spiraling molecule since 1928. When McCarty joined the project in 1941, bringing his strong skills in biochemistry to the task, the answer began to quickly unfold. Nobel Prize winner Dr. Joshua Lederberg, Rockefeller's president emeritus, a longtime colleague and friend, wondered why the pioneering team was overlooked for the top honor in science. "Many Nobelists have said this was the biggest mistake the Nobel committee ever made, by not awarding the prize to Avery and his group," Lederberg said yesterday. "This was the pivotal discovery in biology in the 20th century because it really put DNA on the map. Once that work was done you really couldn't think much about genetics without thinking about DNA," Lederberg said. "Genes were no longer mysterious and inscrutable. Mac helped give [genes] personality as well as importance." Without the 1944 discovery, it would have taken years for scientists such as James Watson, Francis Crick and Maurice Wilkins to determine DNA's structure, as they were able to do in 1953. Watson, Crick and Wilkins were awarded a Nobel Prize for their work. Despite having been passed over for the Nobel, McCarty won dozens of scientific honors, including in 1994 the prestigious Albert Lasker Award for Special Achievement in Medical Science. Rockefeller University honored McCarty in 2001 with the Centennial David Rockefeller Award for Extraordinary Service to The Rockefeller University. McCarty was born in South Bend, Ind., on June 9, 1911, and graduated from Stanford University in 1933. In 1937 he received a medical degree from Johns Hopkins University and specialized in pediatrics. He achieved world reknown for his work with streptoccocal bacteria, the cause of rheumatic fever and once a formidable killer of children. He made inroads in the early 1940s in studies of sulfonamide medications, forerunners to modern antibiotics. Twenty years ago McCarty authored the book, "The Transforming Principle," his recollection of the events leading to the discovery that DNA was indeed the hereditary material and the basic blueprint of life. Until last year he served as the editor of the Journal of Experimental Medicine. "He was the most genial, generous, thoughtful, considerate, insightful and compassionate person you'd ever want to meet. We all admired what he had done," Lederberg said, adding McCarty helped pave the way for modern molecular biology. McCarty is survived by his wife, Marjorie of Manhattan; two sons, Richard E., and Colin Avery McCarty; a daughter Dale Dinunzio; eight grandchildren and five great-grandchildren. Funeral plans are pending. http://www.newsday.com/news/health/ny-hsobit054104667jan05,0,6636298.story?coll=ny-health-headlines
waldron
15/11/2004
13:12
Forensic science degrees queried Students hoping to be the next Sam Ryan may be disappointed Concerns have been raised about the content of forensic science courses, following a surge in their popularity. Television dramas like Silent Witness and Waking the Dead have led many students to apply for such courses. But the Science, Engineering and Manufacturing Technologies Alliance (Semta) says the content is often not sufficiently rigorous. Semta warns many courses are hybrids, which do not offer the pure science degrees most police forces prefer. The report calls for better quality controls to be brought in to monitor the quality of the 350 forensic science courses on offer. A degree in chemistry or some other pure science to be preferable to a degree in forensic science Semta report Semta's director of science and technology, Richard Smith, said: "Forensic science in its own right has been a success story, in that it has attracted young people to study science, perhaps when they would not have done so before." And he praised universities for having seen an opening for science. "What universities have done in their own right is quite remarkable, in that they've seized a marketing opportunity. "And they've done an extremely good job in being able to promote science, which is great." Pure science But the major concern was that graduates from these courses did not have the detailed grasp of chemistry required by employers. "Both forensic science and other science employers consider a degree in chemistry or some other pure science to be preferable to a degree in forensic science," the Semta report warns. "The few science employers who had knowledge about forensic science degrees criticised the course content for lack of clarity and consistency." Richard Smith said action must be taken for the future: "If we don't get science right now, there is likely to be a paucity in the future and that is not going to address the real skills issues of 2014." A range of groups, including university course lecturers, students, police forces, drugs companies and other science employers were questioned for the report. http://news.bbc.co.uk/2/hi/uk_news/education/4012761.stm
grupo guitarlumber
12/11/2004
07:04
Test could spot Alzheimer's early By Paul Rincon BBC News science reporter A clinical assay could be ready within two years A new nanotechnology-based technique could lead to a test for diagnosing the early signs of Alzheimer's disease. The Bio-Barcode-Assay can recognise ADDL, a protein that accumulates in the brains of sufferers. It is a million times more sensitive than conventional tests and could revolutionise disease detection. In future, it might form the basis not only of a test for Alzheimer's but also for types of cancer, the human form of mad cow disease and HIV. The next exciting step would be to move to blood. If you detect it in blood, you have a huge win Professor Chad Mirkin Details of the technique have been outlined at a one-day conference in London. Until now, doctors had no way of diagnosing Alzheimer's disease in their patients. The disease could only be confirmed after death, by studying brain tissue. "Diagnosis [of Alzheimer's] is 100% accurate post-mortem. What you want is the ability to detect the marker so you can begin to think about new types of therapies," said Professor Chad Mirkin, of Northwestern University in Evanston, US. Professor Mirkin and his research group at Northwestern developed the highly sensitive test by manipulating molecules at the nanometre scale (one billionth of a metre). "We have done the first set of experiments that quantify the number of ADDLs in cerebrospinal fluid," Professor Mirkin said. 'Exciting step' ADDLs are protein bundles which attack nerve synapses in the brains of people with Alzheimer's. "Nobody is able to study this with the existing tools. A nanotechnology-enabled tool is allowing us to study these kinds of markers and link them to disease. "The next exciting step would be to move to blood. If you detect it in blood, you have a huge win." To perform a Bio-Barcode-Assay, researchers select antibodies on the basis of the biomarker they need to detect in a solution. Some antibodies are fixed to magnetic particles while others are attached to spherical gold particles just 30 nanometres in diameter. Strands of DNA are fixed to the gold nanoparticle. When antibodies bind to a target biomarker, it becomes sandwiched between a magnetic particle on one side, and a gold particle and its strands of DNA on the other. Applying a magnetic field brings this entire "complex" out of solution. Researchers then release the DNA strands and use a DNA detection device to recognise their signature sequences. A research assay could be available to scientists within a year, Professor Mirkin said. A clinical assay could be commercialised within two, he added. Professor Mirkin said it could also lead to a test to diagnose breast cancer by detecting the faint presence of a protein called PSA, normally associated with prostate cancer in men. It could also form the basis of a new test for HIV and other diseases in blood screening. The test could be used in GPs' surgeries as well as hospitals, or even by members of the public at home. http://news.bbc.co.uk/2/hi/science/nature/4003593.stm OTHER LINKS http://www.forensic.gov.uk/forensic_t/index.htm
ariane
09/1/2003
14:45
I was talking about .. not the sheep!
jl202
09/1/2003
14:42
balto, its been playing on my mind,, Its the spiky red hair, terrier like eyes and small ears -- call me a cynic, but I bet he used blusher to cover up his freckles at Eton. Also, he hangs around in pubs and smokes joints - clearly (edit: allegedly) a commoner :)
jl202
09/1/2003
14:22
What? Incest? That sounds even worse. Go wash your mouth out!
m.t.glass
09/1/2003
14:16
Charles Spencer
execline
09/1/2003
14:08
......... M.J.Hewitt.............................. Harry Hewitt? Surely not. I mean... - if there were any truth in it, surely MJH would put the millions he's about to make from selling Diana's letters towards the upkeep of his child wouldn't he? (Harry was apparently already a toddler when Hewitt first met Diana)(Anyway the ears are wrong)
m.t.glass
09/1/2003
13:55
Then we have ADVFN filling my screen with green, orange, blue.........actually......well done advfn.
balto
Chat Pages: 9  8  7  6  5  4  3  2  1
ADVFN Advertorial
Your Recent History
LSE
DNA
Doric Nimr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211028 03:23:16